J&J’s US orthopedic leader leaves amid DePuy spinout process
Leslie Storms started a new role on Monday as president of Ethos Veterinary Health.
J&J’s US orthopedic leader leaves amid DePuy spinout process Read More »
Lilly Cuts Zepbound Prices, Again, When Buying Through DTC Program
Following Novo Nordisk’s price cuts for its own GLP-1 medicines, Eli Lilly is offering discounts for the obesity drug purchased through LillyDirect. Both pharmas recently struck a deal with the White House for cheaper prices via the yet-to-be-launched TrumpRx.
Lilly Cuts Zepbound Prices, Again, When Buying Through DTC Program Read More »
Building a better robot: How Virtual Incision plans to challenge Intuitive
Led by former Intuitive executive Jim Alecxih, Virtual Incision expects the miniaturized design of its robot to stand out in an increasingly crowded field of challengers.
Building a better robot: How Virtual Incision plans to challenge Intuitive Read More »
Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B
Protego Biopharma is advancing a small-molecule drug that helps light chain proteins fold correctly, in turn addressing the underlying biological cause of AL amyloidosis.
Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B Read More »
FDA Delays Decision on Ascendis’ Dwarfism Drug By Three Months
If approved, Ascendis’ TransCon CNP would become the second therapy for achondroplasia, challenging BioMarin’s Voxzogo.
FDA Delays Decision on Ascendis’ Dwarfism Drug By Three Months Read More »
FDA’s Prasad Links 10 Child Deaths to COVID-19 Vaccines, Eyes Stricter Review Guidelines
The alleged deaths were detected by the FDA’s Vaccine Adverse Event Reporting System, reports from which “generally cannot be used to determine” causation or even contribution, according to the agency.
FDA’s Prasad Links 10 Child Deaths to COVID-19 Vaccines, Eyes Stricter Review Guidelines Read More »
Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD
The centerpiece of the deal is the in vivo editor TSRA-196, which in preclinical studies has shown robust editing at SERPINA1, the locus linked to alpha-1 antitrypsin deficiency.
Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD Read More »
La combinación de dos fármacos contra el riesgo cardiovascular también podría servir contra la enfermedad hepática metabólica
La enfermedad hepática metabólica es la patología del hígado más común en el mundo: afecta a un tercio de la población adulta aproximadamente. Este trastorno se caracteriza por la acumulación de grasa en las células del hígado, lo …
Nuevos avances para impulsar la regeneración y la plasticidad de las neuronas
Todavía no se conocen con detalle los mecanismos que tiene el cerebro para reparar las lesiones causadas por traumatismos o enfermedades degenerativas. Ahora, unos científicos han ideado una estrategia basada en la terapia con células madre que podría potenciar la regener …
Nuevos avances para impulsar la regeneración y la plasticidad de las neuronas Read More »
Comienza la misión HydroGNSS para estudiar desde el espacio el inventario del agua de la Tierra
El 28 de noviembre de 2025, los dos satélites gemelos HydroGNSS de la Agencia Espacial Europea (ESA) fueron lanzados al espacio, junto con otros satélites, por un cohete Falcon 9 de SpaceX. El lanzamiento se efectuó desde la base de la Fuerza Espacial estadounidense de Vandenber …